Clinical Trials · NCT00845507
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Cincinnati
- Enrollment
- 54
- Start date
- Dec 2008
- Locations
- 1 site, United States
- Primary endpoint
- Change in Weight From Baseline to Endpoint.